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A B S T R A C T
A commercial polymeric ﬁlm (Paraﬁlm M1, a blend of a hydrocarbon wax and a polyoleﬁn) was evaluated
as a model membrane for microneedle (MN) insertion studies. Polymeric MN arrays were inserted into
Paraﬁlm M1 (PF) and also into excised neonatal porcine skin. Paraﬁlm M1 was folded before the
insertions to closely approximate thickness of the excised skin. Insertion depths were evaluated using
optical coherence tomography (OCT) using either a force applied by a Texture Analyser or by a group of
human volunteers. The obtained insertion depths were, in general, slightly lower, especially for higher
forces, for PF than for skin. However, this difference was not a large, being less than the 10% of the needle
length. Therefore, all these data indicate that this model membrane could be a good alternative to
biological tissue for MN insertion studies. As an alternative method to OCT, light microscopy was used to
evaluate the insertion depths of MN in the model membrane. This provided a rapid, simple method to
compare different MN formulations. The use of Paraﬁlm M1, in conjunction with a standardised force/
time proﬁle applied by a Texture Analyser, could provide the basis for a rapid MN quality control test
suitable for in-process use. It could also be used as a comparative test of insertion efﬁciency between
candidate MN formulations.
ã 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
1. Introduction
Microneedle (MN) devices are composed of an array of micron-
size needles. These systems are currently attracting great interest
in transdermal drug delivery research (Chandrasekhar et al., 2013;
Henry et al., 1998; Kim et al., 2012; Tuan-Mahmood et al., 2013).
MN has the ability to pierce the outermost layer of the skin, the
stratum corneum (SC) and create micro-conduits that can deliver
drugs to the deeper layers of the skin from where they can be
absorbed directly into the systemic circulation (Prausnitz, 2004).
Several key physical factors affect MN performance. These are:
type of material, needle height, tip-radius, base diameter, needle
geometry and needle density. The penetration depth and the
fracture force of MN are determined by all these factors (Davis
et al., 2004). Clearly, effective penetration of MN arrays into the
skin is the primary pre-requisite for effective drug delivery.
However, when developing and testing MN systems, it is apparent
that there are limited techniques to evaluate this aspect. Most are
based on the measurement of transepidermal water loss (TEWL)
(Badran et al., 2009; Bal et al., 2008) or in the visualization of the
micropores created after the application of a dye to the skin surface
(Oh et al., 2008; Park et al., 2005; Verbaan et al., 2008; Wang et al.,
2006). An alternative to these techniques is to take a biopsy of the
MN pierced tissue and section it using histological techniques
(Badran et al., 2009; Wang et al., 2006; Widera et al., 2006). In this
latter case, the subsequent treatment of the skin could change the
structure of the micropores. Previously, optical coherence tomog-
raphy (OCT) has been demonstrated as a good option to evaluate
the insertion of MN (Coulman et al., 2011; Donnelly et al., 2010). It
is a non-invasive technique and, in addition to pore diameter, the
penetration depth of the MN can be readily obtained.
MN insertion studies have typically been performed in
biological tissue and this can present some disadvantages, in that
tissue samples are often heterogeneous, unstable and difﬁcult to
obtain. In addition, the use of biological materials sometimes
presents legal issues. Importantly, many of the reported methods,
although valuable during the product development phase, are too
complex to be suitable as a standard, routine quality control (QC)
method for MN. Thus, for QC applications, it is desirable to
overcome these limitations by using an artiﬁcial material in place
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of skin. Critically, this will allow the speed and repeatability of
experiments to be improved. There are many reports on the use of
artiﬁcial membranes for drug diffusion studies generally (Ng et al.,
2012) and, speciﬁcally, for MN mediated transdermal drug delivery
(Donnelly et al., 2009; Garland et al., 2012; Zhang et al., 2014).
Artiﬁcial membranes are widely used for hypodermic needle
mechanical testing and bench tests have been developed and
standardised for this purpose (Vedrine et al., 2003). However, to
the best of our knowledge, studies on artiﬁcial membranes for MN
insertion or mechanical characterization are scarce (Hamilton,
2011; Koelmans et al., 2013; Muthu, 2007). The implementation of
an artiﬁcial membrane method for insertion studies can also
provide valuable and important comparison tool between different
types of MN arrays.
In this work, we propose the use of a polymeric ﬁlm as a model
for MN insertion studies. A comparative study between the
insertion of MN into this material and excised neonatal porcine
skin was carried out. OCT was used as a tool to evaluate the
insertion of MN inside the tissue, taking into account aspects such
as the insertion force. Additionally, the force that patients use to
apply MN arrays to their skin was evaluated. To the best of our
knowledge, there are no studies relating test conditions to actual
real life use of MN, in the context of skin insertion by patients, a key
factor in designing a reliable QC test method.
2. Materials and methods
2.1. Materials
Gantrez1 S-97 (Mw= 1.2  106), a copolymer obtained from the
free acid of methyl vinyl ether and maleic anhydride polymers, was
provided by Ashland (Tadworth, Surrey, UK). Poly(ethyleneglycol)
(PEG) 10,000 Da was obtained from Sigma–Aldrich (Poole, Dorset,
UK). Paraﬁlm M1, a ﬂexible thermoplastic sheet (127 mm
thickness) made of oleﬁn-type material, was used as skin simulant
for insertion studies, was obtained from BRAND GMBH (Wertheim,
Germany). Deka1 poly(urethane) needle testing foil was provided
by Melab GmbH (Leonberg, Germany).
2.2. Methods
2.2.1. Preparation of MN arrays
To fabricate MN, aqueous blends containing Gantrez1 S-97 (20%
w/w) and PEG 10,000 (7.5% w/w) were micromoulded in laser-
engineered silicone micromould templates, as previously de-
scribed (Donnelly et al., 2010, 2011; Migalska et al., 2011; Garland
et al., 2011; Singh et al., 2009, 2010). Three different MN
geometries were used (Table 1). Light microscope images of the
two main MN arrays used in this work can be seen in Fig. 1A.
Alternatively, two different formulations were used to prepare
either brittle (prepared by adding sodium carbonate 3.5% w/w to
the original formulation) or ﬂexible (prepared by replacing PEG in
the original formulation with 10% w/w glycerine) MN arrays. In the
preparation of brittle and ﬂexible formulations the MN was not
crosslinked (Donnelly et al., 2012a).
2.2.2. Human manual force measurements
The forces that 20 volunteers applied using their thumbs were
measured using a TA.XTPlus Texture Analyser (Stable Micro
Systems, Surrey, UK). The selected volunteers were 10 males
and 10 females aged between 20 and 35 years. The volunteers were
asked to apply the same force they would use to push an elevator
button or to press a stamp onto an envelope, using their right
thumb and a 30 s application period, as shown in Fig. 1B. The
Texture Analyser was used in tension mode to register the force
curves. Three different parameters were determined from these
curves: the maximum, minimum and average forces applied
during this time interval (Fig. 1C).
2.2.3. Insertion of MN arrays
Full thickness neonatal porcine skin can be considered a good
model for human skin in terms of hair sparseness and physical
properties (Meyer, 1996). It was obtained from stillborn piglets and
excised <24.0 h after birth. Full thickness skin (0.5 mm) was then
stored in aluminium foil at 20.0 C until further use. Two sections
of skin were placed together, with the dermal side contacting each
other, such that the stratum corneum surface was exposed at either
side, giving a total skin thickness of about 1 mm. This was then
utilised for the OCT assessment of MN penetration.
As an alternative to neonatal porcine skin, Paraﬁlm M1 (PF) ﬁlm
and a needle testing polyurethane ﬁlm were used as skin
simulants. A sheet of Paraﬁlm was folded to get an eight-layer
ﬁlm (1 mm thickness) and a poly(urethane) needle testing ﬁlm
(Deka1) was used as received (0.4 mm thickness). The skin/
Paraﬁlm1 was then placed onto a sheet of expanded poly
(ethylene) for support.
Two insertion methods were carried out: manual and Texture
Analyser insertion. For manual insertion, different volunteers were
recruited to apply the MN arrays following the same instructions as
in the force measurement experiment. The Texture Analyser
insertion was performed using a TA.XTPlus Texture Analyser
(Stable Micro Systems, Surrey, UK) in compression mode. MN
arrays were placed on the surface of the skin/artiﬁcial membrane
and sticky tape (Ofﬁce Depot, Boca Raton, USA) was carefully
applied on the upper surface without applying force (Fig. 1D). The
probe was lowered onto the skin/artiﬁcial membrane at a speed of
0.5 mm s1 until the required force was exerted. Forces were held
for 30 s and varied from 10 N to 50 N per array. Once the target force
was reached, the probe was moved upwards at a speed of
0.5 mm s1.
2.2.4. Optical coherence tomography
Inserted MN arrays were immediately viewed using an EX1301
OCT Microscope (Michelson Diagnostics Ltd., Kent, UK). The swept-
source Fourier domain OCT system has a laser centre wavelength of
1305.0  15.0 nm, facilitating real-time high-resolution imaging of
the upper skin layers (7.5 mm lateral and 10.0 mm vertical
resolution). The skin was scanned at a frame rate of up to 15 B-
scans (2D cross-sectional scans) per second (scan width = 2.0 mm).
The 2D images were analysed using the imaging software ImageJ1
(National Institutes of Health, Bethesda, USA). The scale of the
image ﬁles obtained was 1.0 pixel = 4.2 mm, thus allowing accurate
measurements of the depth of MN penetration and the width of
pore created. Three replicates were performed, and the insertion
depths of 25 MN were measured in total.
2.2.5. MN insertion testing using light microscopy
MN arrays were inserted using a Texture Analyser, as described
above, into eight-layer folded PF sheets. In these cases, sticky tape
was not used. After the insertion, the MN arrays were removed
from the polymeric sheet. The PF was unfolded and the number of
holes in each layer was evaluated using a Leica EZ4 D digital
Table 1
Physical properties of the different MN arrays.
MN per array Height
(mm)
Width at base (mm) Interspacing at base (mm)
11 11 600 300 300
11 11 900 300 300
19  19 600 300 50
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microscope (Leica, Wetzlar, Germany). In order to easily detect the
holes created in the PF layers, two polarizer ﬁlters were used. The
sample was placed between these two ﬁlters.
In order to evaluate the thickness of a PF layer, the thickness of
20 samples was evaluated using a digital micrometer (HZH, China).
These samples (5) were collected from four different PF rolls.
2.2.6. Statistics
All data are expressed as mean  standard deviation. Data were
compared using a paired, two-tailed Student’s t-test. In all cases,
p < 0.05 was the minimum value considered acceptable for
rejection of the null hypothesis.
3. Results
3.1. Measurement of human volunteers application force
Fig. 2 shows the measured force that 20 human volunteers (10
M, 10 F) applied with their thumbs using the same force that they
would apply to an elevator button or a postage stamp for 30 s. The
obtained average force was around 20 N (19 N F and 21 N M).
Additionally, Fig. 2 shows the maximum and minimum forces
applied by the volunteers, to illustrate the variability of the applied
forces during the 30 s insertion time.
3.2. Manual insertion of MN arrays
In order to investigate the inﬂuence of the manual application
force in the MN insertion and to determine if PF can adequately
mimic human skin for insertion studies under the same conditions,
a group of ﬁve human volunteers were recruited for this study.
They were asked to apply a force with their thumbs, as before, to
11 11 MN arrays in order to insert them into neonatal porcine skin
and PF. Fig. 3A shows the penetration depths of two types of MN
arrays evaluated using OCT. There are signiﬁcant differences
between the insertion in skin and in PF in almost all the cases, with
PF having lower insertion depths than neonatal porcine skin
(p < 0.05). Nevertheless, the differences are typically less than the
10% of the total needle length, with the insertion of a 600 mm MN
array by volunteer 1 presenting the higher difference at 10.2% of
the needle length. However, the range of forces that this volunteer
applied was larger than than the rest of the volunteer cohort.
Fig. 4A and B shows OCT images of an 11 11 MN array inserted
into neonatal pig skin and PF respectively, applied by the same
volunteer.
In addition, another polymeric membrane was used as skin
simulant for insertion studies. This poly(urethane) membrane is
normally used for hypodermic needle penetration testing. It was
very elastic and, consequently, MN could not penetrate it properly
(Fig. 4C). This kind of membrane was previously reported
(Koelmans et al., 2013) for MN testing as a stratum corneum
simulant with good results. However, the MN in this case were of
metal rather than polymeric construction and thus more akin to a
hypodermic needle. After insertion of Gantrez polymeric MN, the
holes created in this membrane were more like small indentations
and were very difﬁcult to see, even using a microscope. In contrast
the holes created in PF were easily checked, even without a
microscope.
Fig. 1. Light microscope images of 600 (i) and 900 (ii) mm length 11 11 MN arrays (A). Schematic illustrations: Texture Analyser set up for the measurement of human
manual force (B). Example of curve obtained in the manual force measurements (C) and Texture Analyser set up for the insertion of MN arrays (D).
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The average force that ﬁve volunteers applied with their
thumbs to the MN arrays during 30 s was measured separately.
These results can be correlated with the penetration depths of MN
(Fig. 5). As expected, the volunteers that independently were found
to apply the highest forces performed the deeper insertions. It is
important to notice that in these curves there is a plateau at the
end. In addition, as pointed out in the insertion comparison
between PF and skin the insertion curves are equivalent. The
signiﬁcant differences can be found for the higher forces. This can
be explained considering the higher range of applied forces of
these two volunteers. In addition, despite the signiﬁcant differ-
ences between the insertions in both materials (skin and PF), their
insertion curves show the same trend and can be overlapped.
3.3. Texture Analyser insertion of MN arrays
In order to use a controlled force for insertion, the Texture
Analyser was used. Fig. 6 shows the insertion depths of 11 11 MN
in PF and in neonatal porcine skin for two different forces applied
by a Texture Analyser. As can be seen for the higher force (40 N)
there are signiﬁcant differences between the insertions (p < 0.05).
This is consistent with the results obtained for manual insertions
where the larger differences were present for the higher insertion
forces. However, when the insertion force was lower (10 N),
signiﬁcant differences between insertions of MN arrays into
neonatal pig skin were not found (p = 0.257).
Fig. 7A shows the insertion depths of 11 11 MN in PF as a
function of the force applied by a Texture Analyser. As expected,
900 mm MN arrays showed deeper insertions than those of
600 mm (p < 0.05). In both cases, the obtained force/insertion
curves are similar to those of the same MN arrays inserted
manually, reaching the same plateau insertion values (between
300 and 400 mm for 600 mm MN arrays, and between 500 and
600 mm for 900 mm arrays). If the density of the MN in the array is
increased the insertion will be different (Verbaan et al., 2008). In
Fig. 7B, the comparison between the insertion of 11 11 and
19  19 MN arrays with the same needle length (600 mm) can be
seen. It is noticeable that the penetration depths of 19  19 MN
arrays are signiﬁcantly lower than the 11 11 arrays (p < 0.05).
Only for 30 N force can the insertions be considered equivalent
(p = 0.135), but for these higher forces (30, 40 and 50 N) it is
sometimes difﬁcult to ascertain the insertion using OCT for 19  19
MN in PF. Thus, the measurements for this MN array (19  19 MN)
were not very reliable and an alternative method is required.
All the reported data were obtained by applying certain force
with the Texture Analyser during a time period of 30 s. The
Fig. 2. Manual maximum (A and D), minimum (B and E) and average (C and F) forces applied by 10 female volunteers (grey bars) and 10 male volunteers (white bars) in a 30 s
time interval. The dashed lines indicate the average force in each case.
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inﬂuence of the application time can be observed in Fig. 8. When
the force was applied for only 1 s the insertion was slightly lower.
Nevertheless, there are signiﬁcant differences between insertions
of MN arrays during 1 s and 30 s (p < 0.05). The only exception is
the 40 N insertions of 600 mm MN arrays (p = 0.271). This suggests
that, for a reliable MN insertion, longer times are preferred. Thus,
further tests were carried out using 30 s as the insertion time.
3.4. MN insertion testing using light microscopy
An alternative to OCT in PF insertion studies could be the
evaluation of the number of holes created in each layer of the PF
sheet after the application of a MN array (Fig. 9D). Fig. 9 shows the
percentage of holes created in each PF layer for different types of
MN arrays and two different forces (10 and 40 N). After measuring
the average thickness of a PF layer (126  7 mm) the percentage of
MN inserted as a function of the depth can be calculated (Fig. 9). As
expected using an insertion force of 40 N, 900 mm 11 11 MN
arrays reached lower PF layers than 600 mm 11 11 MN examples.
However, 19  19 arrays were found to have only pierced two PF
layers. These results are consistent with those obtained using OCT.
The same insertion proﬁles were observed with a lower insertion
force (10 N) but the MN arrays did not pierce as many layers of PF.
Theseresults can becomparedwiththeinsertiondepthsobtained
using OCT (dashed vertical lines in Fig. 9). The number of holes
created decreased with the insertion depth. However, it is important
to remember that, in the OCT-based study, the factor that is evaluated
is whether the needles went through an entire layerof PF. Sometimes
Fig. 3. Insertion (A) and pore diameter (B) in pig skin and Paraﬁlm using manual application for 600 (i) and 900 (ii) mm MN arrays.
Fig. 4. OCT images of a 11 11 MN array inserted manually by the same volunteer in different materials: neonatal pig skin (A), eight layers of PF (B) and needle testing ﬁlm (C).
To allow differentiation between MNs a red false colour were applied in the skin/ﬁlm layers. The original pictures without this colour can be found on the Supplementary
content (Fig. S1). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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it isdifﬁcult todetermineif the createdhole extendsacross thewhole
PF layer. Consequently, this test canyield a range of depths of 126 mm
instead of an exact value of insertion depth.
Not all MN arrays can be inserted successfully. There are
formulations that can fail the insertion test. For a prospective QC
test to be useful, it must be able to demonstrate lack of penetration
for ineffective formulations. Thus, two formulations were used to
prove two different failure cases. The ﬁrst formulation was that
used throughout this work but with an additional 3.5% (w/w) of
sodium carbonate that acts as a pore forming agent in order to
make the formulation more swellable. These MN were not heated
at 80 C to crosslink the Gantrez polymer. Thus, the resulting MN
was very brittle and cannot be properly inserted into the PF
because the base plate of the array was broken after application of
a 40 N force (Fig. 10A). Replacing the PEG with glycerine and
avoiding the crosslinking step resulted in a very ﬂexible formula-
tion. As can be seen in Fig. 10B, these formulations could not been
inserted because the MN tips were bent (Fig. 10B).
4. Discussion
Scale-up of manufacturing technologies is a key challenge in the
development of polymeric MN transdermal systems. An important
aspect is the availability of a rapid, simple and standardised QC test
method to determine MN penetration characteristics. Such a test is
also important in MN array development as a tool to compare
candidate MN formulations. Since skin is highly variable and
presents a number of other difﬁculties for these purposes, the
identiﬁcation of an inexpensive, readily obtainable and inexpen-
sive model membrane is important if such a test is to be developed.
In developing a suitable insertion test it is important to know how
MN will be used. As an emerging pharmaceutical technology, MN
should be patient-friendly, i.e. easy to apply and to remove. In many
MN studies, the arrays are applied using various types of applicators
(Donnelly et al., 2012b). The use of these devices makes the insertion
force very reproducible. However, the use of manual application, if
possible, will simplify the insertion process for the patient. In a
previous study, manual self-application of MN arrays was evaluated
successfully (Donnelly et al., 2014). The main drawback of manual
insertion is that the force that an individual applies to a MN array can
vary depending on different factors such as age, gender and body
weight. Knowing this range of forces could be very useful to design a
standardised insertion test for future MN studies.
In this work, we developed a simple experiment to measure the
range of forces that patients can apply to polymeric MN arrays. The
obtained average forces were about 20 N (Fig. 2). In previous work,
the range of forces needed to insert different types of MN was
found to be lower than 20 N (Davis et al., 2004; Koelmans et al.,
2013; Kong et al., 2011). It is noticeable that the average forces for
MN insertion between male and female volunteers was not
signiﬁcant. The volunteer insertion force data inform the range of
Fig. 5. Insertion of 11 11 MN in pig skin (A) and PF (B) as a function of the average manual force for different MN heights. 600 (i) and 900 (ii) mm.
Fig. 6. Insertion depths of 600 mm 11 11 MN arrays in PF and in neonatal porcine
skin for two different forces applied by a Texture Analyser.
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forces that should be used in a standardised MN insertion test
using an artiﬁcial membrane.
In order to evaluate if PF is a good alternative to skin for this
kind of test, manual insertion in neonatal pig skin and PF were
carried out using human volunteers. The results obtained in these
experiments suggest that, despite presenting slightly lower
penetration depths than porcine skin, PF could be a promising
material to replace biological tissue for insertion studies. In
previously reported studies, different kinds of artiﬁcial ﬁlms and
material were used to test MN (Hamilton, 2011; Koelmans et al.,
2013; Muthu, 2007; Zhang et al., 2014). The insertion in these cases
was about 60% of the total needle length, but these results correlate
well with the insertion depths obtained in an earlier study using
the same type of polymeric MN in human volunteers with manual
application (Donnelly et al., 2014).
The forces that ﬁve volunteers applied with their thumbs can be
correlated with MN penetration depths (Fig. 5). In these curves a
plateau can be found for higher forces. This means that, due to skin
mechanical properties, this kind of MN cannot be totally inserted
using a range of forces between 0 and 50 N. Importantly, this
behaviour was also seen in PF insertions.
In order to have a more systematic insertion study, a Texture
Analyser was used to insert different MN arrays. The ﬁrst step was
to compare the insertion in neonatal porcine skin and PF. The
insertion forces were selected taking into account the data
obtained from the human volunteer study (range between 0 and
50 N per array). The results showed that there were no signiﬁcant
differences between the two membranes in respect of MN
insertion depths, but only for relatively low insertion forces
(10 N/array). This is consistent with results obtained for manual
insertion of MN arrays, where the lower differences between
penetration depths were found for the lower insertion forces.
If PF is going to be used for further studies as a model
membrane in MN insertion testing, it is of crucial importance to
control and evaluate the behaviour and insertion characteristics
when MN are inserted. The insertion depth/force curves (Fig. 6) for
different MN arrays presented the same pattern as those obtained
with manual insertion, with a plateau for higher forces. This
demonstrates that the insertion proﬁles of these kind of MN arrays
are very reproducible and do not depend strongly on how the force
is applied.
Another noticeable aspect is that the depths of insertion of
19  19 MN arrays are lower than that of 11 11. This is consistent
with the bed of nails effect (Verbaan et al., 2008). Sometimes, this
effect is not observed experimentally depending on the number of
MN per array or the insertion method (Verbaan et al., 2008; Widera
et al., 2006).
Finally, the last aspect that was evaluated was the insertion
time. By reducing this time to 1 s for a deﬁned force value, it was
found that the insertion depths in PF are similar (Fig. 7). However,
for fully effective insertion, longer application times will improve
the penetration depth.
Taking into account all of the data, an easy, inexpensive and
reliable insertion test is proposed. The PF membrane used for these
insertion studies consisted of eight folded layers. This method allows
the evaluation of the number of holes created in each layer of the PF
sheet. As the thickness ofeach layer isknown, the insertiondepthcan
be readily estimated without using complex techniques such as OCT,
Fig. 7. Insertion depths of 11 11 (A) and 19  19 (B) MN arrays in PF as a function of the force applied by a Texture Analyser.
Fig. 8. Insertion depths of 600 and 900 mm 11 11 MN arrays in PF as a function of the insertion time for two different forces: 10 N (A) and 40 N (B).
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making the test very suitable as an in-process QC method. The
insertion proﬁles obtained (Fig. 8) are consistent with the insertion
depths obtained with OCT (Fig. 6). The two different forces that were
used in this test have two purposes. The lower force (10 N) will give
insertion proﬁles equivalent to those obtained using neonatal pig
skin (Fig. 6) and the higher force (40 N) is used to test the strength of
thebaseplate(Fig.10).Therefore, thistest canbeusedtodiscriminate
faulty MN arrays.
5. Conclusion
The proposed MN insertion test can be easily implemented as a
routine method to compare MN formulations and to control the
quality of MN arrays. This can be of value in scaled-up MN
production processes. The test proposed in this study can be used
to complement existing techniques for the physical characteriza-
tion of MN arrays. The key aspects are the identiﬁcation of PF as a
Fig. 9. Percentage of holes created in each PF layer using two different insertion forces (40 N and 10 N) for different types of MN arrays: 600 mm 11 11 (A), 900 mm 11 11 (B)
and 600 mm 19  19 (C). The dashed lines correspond with the obtained values of insertion depth using OCT in each case (see Fig. 5). Photograph of PF layers after the insertion
of 600 mm 11 11 MN arrays using a force of 40 N as insertion force: ﬁrst layer (1), second layer (2), third layer (3) and fourth layer (4).
Fig.10. Photograph of 600 mm 19  19 MN arrays after insertion in PF of two different formulations: Na2CO3 formulation (A) and glycerine formulation (B). The insertion force
was 40 N in both cases.
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suitable skin simulant for MN insertion and the development of a
facile, rapid and reliable insertion test with potential for use as a QC
test method, or for comparative formulation studies.
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